In conclusion, our study identified a novel mechanism by which a glucocorticoid-11β-HSD1 pathway induced insulin resistance through JNK activation in adipocytes Moreover, the results suggest that 11β-HSD1 and its downstream target molecule, JNK, are key therapeutic strategies for treating insulin resistance in response to glucocorticoid excess. This evidence concerns the gene MAPK8 and Insulin resistance.